Quick Heal Technologies Allots 15,352 Equity Shares Under ESOP Scheme 2021

1 min read     Updated on 05 Nov 2025, 08:30 PM
scanx
Reviewed by
Shriram SScanX News Team
Overview

Quick Heal Technologies has executed multiple ESOP transactions including the latest allotment of 15,352 equity shares on December 24, 2025, a previous allotment of 32,205 shares, and a new grant of 48,000 stock options with ₹151.00 exercise price, reflecting the company's commitment to employee retention and motivation in the cybersecurity sector.

23900418

*this image is generated using AI for illustrative purposes only.

Quick Heal Technologies Limited , a prominent player in the cybersecurity sector, has announced multiple employee stock-related developments under its Employee Stock Option Plan (ESOP) Scheme 2021. The company has granted 48,000 new employee stock options and made two separate allotments of equity shares, demonstrating its continued commitment to employee incentivization.

Latest ESOP Allotment

On December 24, 2025, Quick Heal Technologies allotted 15,352 equity shares under its ESOP Scheme 2021. The company filed the notification under Regulation 10(c) with both BSE and NSE on the same date.

Particulars: Details
Number of Shares Allotted: 15,352
Date of Issue: December 24, 2025
Face Value per Share: ₹10.00
Distinctive Numbers: 7,22,02,485 to 7,22,17,836
Permanent ISIN: INE306L01010

Previous ESOP Activities

Earlier, the company had allotted 32,205 equity shares under the same ESOP Scheme 2021 on November 5, 2025. This previous allotment had distinctive numbers ranging from 7,21,61,177 to 7,21,93,381 and involved multiple exercise prices ranging from ₹10.00 to ₹291.00.

New Stock Option Grant

The Nomination and Remuneration Committee has also approved the grant of 48,000 employee stock options to eligible employees with the following terms:

Grant Details: Specifications
Exercise Price: ₹151.00 per share
Face Value: ₹10.00 each
Vesting Schedule: 4-year schedule with 25% vesting annually
Exercise Window: 3 years post-vesting

Share Capital Impact

With the latest allotment of 15,352 shares, combined with the previous allotment of 32,205 shares, Quick Heal Technologies has issued a total of 47,557 new equity shares under its ESOP scheme. The newly allotted shares are identical in all respects to the existing equity shares and will be credited to the company's permanent ISIN INE306L01010 upon receiving final trading approval.

Strategic Significance

These ESOP activities reflect Quick Heal's strategic focus on talent retention and employee motivation in the competitive cybersecurity industry. By aligning employee interests with shareholder value through equity participation, the company aims to foster long-term commitment and drive organizational growth.

Historical Stock Returns for Quick Heal Technologies

1 Day5 Days1 Month6 Months1 Year5 Years
-3.19%-8.32%-12.77%-38.00%-60.08%+42.07%
Quick Heal Technologies
View in Depthredirect
like19
dislike

Quick Heal Technologies Reports Strong Q2 FY26 Recovery with 13.6% Revenue Growth

2 min read     Updated on 15 Oct 2025, 11:03 PM
scanx
Reviewed by
Shriram SScanX News Team
Overview

Quick Heal Technologies Limited announced robust Q2 FY26 financial results, with revenue increasing 13.6% YoY to ₹83.50 crores. EBITDA surged 200.7% to ₹9.20 crores, while PAT grew 90.6% to ₹7.90 crores. The enterprise segment revenue rose 30% YoY to ₹36.90 crores, and consumer segment revenue increased 8.3% to ₹59.50 crores. The company onboarded its first enterprise customer for the Seqrite Data Privacy Management Platform and signed an MOU with BHASHINI for AI-powered cybersecurity solutions. Quick Heal continues to expand internationally and received industry recognition for its cybersecurity services.

22095212

*this image is generated using AI for illustrative purposes only.

Quick Heal Technologies Limited , a leading global cybersecurity solutions provider, has announced its financial results for the second quarter of fiscal year 2026, showcasing a robust recovery and growth across its business segments.

Financial Highlights

The company reported a significant improvement in its financial performance for Q2 FY26:

Metric Q2 FY26 Q2 FY25 YoY Change
Revenue ₹83.50 crores ₹73.50 crores 13.6% ↑
EBITDA ₹9.20 crores ₹3.10 crores 200.7% ↑
EBITDA Margin 11.1% 4.2% 690 bps ↑
PAT ₹7.90 crores ₹4.20 crores 90.6% ↑
PAT Margin 9.5% 5.7% 380 bps ↑

Segment Performance

Quick Heal's performance was driven by growth in both its enterprise and consumer segments:

  • Enterprise Revenue: ₹36.90 crores, up 30% year-over-year
  • Consumer Revenue: ₹59.50 crores, up 8.3% year-over-year

Key Developments

  1. Data Privacy Management Platform: Quick Heal onboarded its first enterprise customer for the Seqrite Data Privacy Management Platform, which aids enterprises in achieving and maintaining compliance with privacy laws like the DPDP Act.

  2. AI-Powered Cybersecurity: The company signed an MOU with BHASHINI to integrate Seqrite's AI-powered cybersecurity modules into India's multilingual AI platform, offering data privacy solutions in 22 languages.

  3. International Expansion: Quick Heal continues to see growth in international revenue, driven by new market entries in Southeast Asia and the Middle East.

  4. Awards and Recognition: Seqrite received the "Cybersecurity Service Provider of the Year" Award at the Times Secure India Summit 2025, while Quick Heal won "The Leading Cybersecurity Solutions Brand of 2025" at NCN Excellence Awards.

Management Commentary

Dr. Kailash Katkar, Chairman and Managing Director of Quick Heal Technologies Limited, commented on the results: "Q2 FY26 witnessed good performance across both verticals of our business, which is a clear reflection of the resilience and diversification of our cybersecurity portfolio through continued investments in differentiated, AI-led innovations. The consumer business has shown recovery with seasonal tailwinds, while our enterprise vertical continues to gain momentum through innovative solution offerings."

Ankit Maheshwari, Chief Financial Officer, added: "We are pleased with the revenue growth momentum this quarter. Owing to the stable cost structures, the revenue improvement enabled us to restore healthy margins. Our continued investments in R&D and S&M for market expansion are key tenets for our long-term pivot and have started to show positive traction."

Future Outlook

As Quick Heal Technologies moves into the second half of the fiscal year, the company remains focused on scaling its AI-led innovations, expanding partner ecosystems, and driving predictable growth. With a healthy order pipeline and a diversified revenue mix, Quick Heal is well-positioned to deliver sustainable shareholder value in the evolving cybersecurity landscape.

The company's strategic focus on both consumer and enterprise segments, coupled with its expansion into international markets and investment in cutting-edge technologies like AI, positions it strongly for continued growth in the global cybersecurity market.

Historical Stock Returns for Quick Heal Technologies

1 Day5 Days1 Month6 Months1 Year5 Years
-3.19%-8.32%-12.77%-38.00%-60.08%+42.07%
Quick Heal Technologies
View in Depthredirect
like17
dislike
More News on Quick Heal Technologies
Explore Other Articles
244.50
-8.05
(-3.19%)